共 230 条
- [1] Tosi F(2017)Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis Clin Colorectal Cancer 16 e153-e163
- [2] Magni E(2019)Colorectal liver metastases: an update on multidisciplinary approach World J Hepatol 11 150-172
- [3] Amatu A(1999)Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 309-318
- [4] Mauri G(2010)Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) 12 227-238
- [5] Bencardino K(2018)Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases ANZ J Surg 88 E16-E20
- [6] Truini M(2020)Coaltered Ras/B-raf and TP53 is associated with extremes of survivorship and distinct patterns of metastasis in patients with metastatic colorectal cancer Clin Cancer Res 26 1077-1085
- [7] Chow FC-L(2020)Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases Oncol Lett 20 2119-2130
- [8] Chok KS-H(2015)Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases Br J Surg 102 1175-1183
- [9] Fong Y(2015)Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases Ann Surg Oncol 22 4158-4165
- [10] Fortner J(2021)Association of RAS mutation location and oncologic outcomes after resection of colorectal liver metastases Ann Surg Oncol 28 817-825